Effectiveness of Barbari( ocimum bacillicum )arka gel in eczema

OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRAIL TO EVALUATE THERAPEUTIC EFFICACY OF OCIMUM BASILICUM ARKA GEL IN THE MANAGEMENT OF ATOPIC DERMATITIS - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084161

Enrollment

Registered

2025-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the criteria of diagnosis according to EASI & SCORAD clinical scale for Atopic dermatitis. 2.Patient alredy dignosed with Atopic dermatitis with or without medication . 3.Patient willing to sign informed consent and able to participate in the study procedure

Exclusion criteria

Exclusion criteria: 1.K/c/o Diabetes mellitus 2.Ptient suffering from immunocompromised disease 3.Patient suffering from other skin disease 4.Patient allergic to trail drug or certain medication

Design outcomes

Primary

Measure	Time frame
1.Reduction in itching & dryness at lesion siteTimepoint: Upto 14 days ,application of gel twice a day on daily bases	—

Secondary

Measure	Time frame
1.almost 90% reduction of atopic dermatitis 2.Improvement in overall skin of lesion siteTimepoint: by 28 days ,while application of gel twice a day at affected area	—

Countries

India

Contacts

Public ContactDr Rekha Parmar

Parul Institute of Ayurved

rekha.parmar@paruluniversity.ac.in9724306523

Outcome results